MennoGeusens

Associate

Amsterdam + 31.20.305.4205

Connect:

Share

Menno Geusens is an experienced associate with a strong focus on multijurisdictional transactions, including M&A (private and public), joint ventures, and corporate restructurings. He also advises clients on general corporate matters, including corporate governance. Menno represents private and public companies, including private equity firms.

Key representations at Jones Day include: Aurelius Equity Opportunities in the controlled auction sale of Getronics Group; Total in the $3.2 billion sale of specialty chemical affiliate Atotech; Gimv, Draper Esprit, and Robert Bosch Ventures on the sale of GreenPeak Technologies; XIO Group on its $510 million acquisition of Lumenis Ltd; BioMarin Pharmaceutical on its $680 million acquisition of Prosensa Holding N.V.; and Gimv in various investments (including its investments in Joolz, a unique fast-growing premium pushchair brand, and United Dutch Breweries [UDB], an independent beer group).

Prior to the opening of Jones Day's Amsterdam Office in 2013, Menno worked for more than two years at the Amsterdam office of another international law firm.

Menno was one of the founders, and serves as a board member, of Forward, the first Legal LGBT Network in the Netherlands. He is also regularly involved in various pro bono activities and projects of the Firm.

Menno was a nominee for the M&A Young Talent Award 2016 of the Dutch M&A Community.

Experience

  • Avient to acquire DSM Protective Materials businessJones Day is advising Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable material solutions, in its $1.485 billion purchase of Koninklijke DSM N.V.’s protective materials business, a leading specialty engineered materials business built around the invention of Dyneema®, the world’s strongest fiber.
  • Gilde Healthcare establishes Gilde Healthcare Private Equity IVJones Day advised Gilde Healthcare Partners B.V. in the establishment of Gilde Healthcare Private Equity IV, a private equity fund that invests in profitable healthcare companies operating in the lower mid-market in North-west Europe.
  • Fortino Capital, Ventech, henQ and founders sell inSided B.V. to Vista portfolio company Gainsight Inc.Jones Day advised Fortino Capital, Ventech, henQ and founders in the sale of inSided B.V. to Vista Equity Partners portfolio company Gainsight Inc.
  • DAS sells credit management business Cannock ChaseJones Day assisted DAS Holding N.V. and DAS Legal Finance in the sale of their credit management business, Cannock Chase, by means of an auction sale process.
  • Climate Fund Managers announces first close of CI2, its second global climate fund, at $675 millionJones Day represented Climate Fund Managers (CFM) with the structuring, establishment, fund raising and first closing of the new fund, CI2 Construction Equity Fund, that invests in water, sanitation and oceans infrastructure projects in Africa, South and South East Asia, and Latin America.
  • Smithers acquires SspJones Day advised The Smithers Group in the acquisition of Red Knot B.V. and SSP Analytical Services B.V., providers of loading and discharge supervision, weight / tallying control, sampling, sample preparation and laboratory testing and trade verification services.
  • Greystar announces €725 million close for flagship pan-European closed-end value-add residential strategyJones Day advised Greystar Europe Investment Management B.V., a subsidiary of Greystar Real Estate Partners, LLC, on the closing of €725 million in equity commitments into its flagship pan-European value-add discretionary vehicle.
  • Solmax acquires TenCate GeosyntheticsJones Day advised Groupe Solmax Inc. (Solmax), the global leader in the production of high-quality polyethylene geomembranes for industrial and environmental applications, and its shareholders (including institutional investors Caisse de dépot et placement du Québec and Fonds de Solidarité FTQ), in connection with Solmax’s acquisition of TenCate Geosynthetics Holding B.V., a global provider of geosynthetics and industrial fabrics, from Dutch conglomerate Koninklijke Ten Cate (Royal Ten Cate, the Netherlands), and advised on the related senior secured financing to support the acquisition.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Catawiki raises €150 million investment led by PermiraJones Day advised Catawiki B.V., Europe's leading curated online marketplace for special objects, on a €150 million investment, led by Permira through its Growth Opportunities Fund.
  • Verint Systems separates into two independent companiesJones Day advised Verint® Systems Inc. ("Verint") in the separation and spin-off of its cyber intelligence business, Cognyte Systems Ltd.
  • SkinVision has raised an investment from Rubio Impact VenturesJones Day advised SkinVision on the investment by Rubio Impact Ventures and existing shareholders.
  • Laureate Education to sell Brazilian operations to Ânima Holding S.A. for R$4.6 billionJones Day acted as special tax counsel to Laureate International, Inc. in the sale of its Brazilian operations to Ânima Holding S.A. for R$4.6 billion.
  • Laureate Education divests operations in Chile to Fundación Educación y Cultura and sale of its for-profit operations for $218.2 millionJones Day acted as special tax counsel in the divestiture of its operations in Chile through the transfer of control of its not-for-profit institutions to Fundación Educación y Cultura and the sale of its for-profit operations.
  • Diebold Nixdorf completes offering of $700 million of Senior Secured NotesJones Day represented Diebold Nixdorf, Incorporated, a global leader in driving connected commerce for the banking and retail industries, in connection with the issuance of its $700 million aggregate principal amount of 9.375% Senior Secured Notes due 2025 in a Rule 144A and Regulation S offering.
  • Diebold Nixdorf completes offering of €350 million of Senior Secured NotesJones Day represented Diebold Nixdorf, Incorporated, a global leader in driving connected commerce for the banking and retail industries, in connection with the issuance by its wholly-owned Dutch subsidiary, Diebold Nixdorf Dutch Holding B.V., of €350 million aggregate principal amount of 9.000% due 2025 in a Rule 144A and Regulation S offering.
  • Aurora Resurgence sold International Cookware to KartesiaJones Day advised Aurora Resurgence, a Los Angeles-based private equity fund, on the sale of International Cookware Group and its subsidiaries to Kartesia, the European specialist provider of capital solutions for small and mid-sized companies.
  • Gilde Healthcare V raises €416 million for its venture and growth capital fundJones Day represented Gilde Healthcare in connection with the establishment of Gilde Healthcare V, a venture & growth capital fund that invests in digital and home health, medtech, diagnostics, research tools and instruments, and therapeutics.
  • HighBrook Property Fund III sells Groothandelsgebouwen (GHG B.V.) to Jamestown, LP for €289 millionJones Day represented HighBrook Property Fund III and its co-investment vehicle, HighBrook III Investment B ("Highbrook"), as lead counsel, in the sale of its 100% interest in Groothandelsgebouwen (GHG B.V.), the largest multi-tenant property in the Netherlands, to Jamestown, LP, an Atlanta, Georgia based real estate investment and management company, for €289 million.
  • Creadev invests in Kingfish ZeelandJones Day represented Creadev SAS in connection with its investment in Kingfish Zeeland BV, a producer of Yellowtail Kingfish via a proprietary recirculating aquaculture system.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.